/KASE, December 5, 2017/ – Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has notified KASE of a KZT14,759,169.00 loan received on November 29, 2017 (in Kazakh and Russian) – see more

[2017-12-05]